Your browser is no longer supported

For the best possible experience using our website we recommend you upgrade to a newer version or another browser.

Your browser appears to have cookies disabled. For the best experience of this website, please enable cookies in your browser

We'll assume we have your consent to use cookies, for example so you won't need to log in each time you visit our site.
Learn more

Bisphosphonate treatment benefits outweigh risks, say researchers

  • Comment

Available evidence shows the benefits of bisphosphonate treatment outweigh the risk of atypical fractures, according to a position statement from the International Osteoporosis Foundation.

A review by researchers, on behalf of the foundation, found atypical fractures from bisphosphonate use were rare.

It follows concerns of a possible link between the two.

The authors said: “The risk versus benefit ratio is clear.

“We estimate that for every 10,000 high-risk patients undergoing bisphosphonate treatment, approximately 100 hip fractures and 750 fractures at other sites are prevented, whereas only three to six atypical fractures could be expected.”

  • Comment

Have your say

You must sign in to make a comment

Please remember that the submission of any material is governed by our Terms and Conditions and by submitting material you confirm your agreement to these Terms and Conditions. Links may be included in your comments but HTML is not permitted.